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Abstract: Background: Cognitive function disturbance is a frequently described symptom of myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS). In this study, the effects of a structured
exercise programme (SEP) upon cognitive function in ME/CFS patients was examined. Methods:
Out of the 53 ME/CFS patients initiating SEP 34 (64%) completed the 16 week programme. Cognitive
function was assessed using a computerized battery test consisting of a Simple Reaction Time (SRT)
(repeated three times) and Choice Reaction Time (CRT) measurements, a Visual Attention Test (VAT)
and a Delayed Matching to Sample (DMS) assessment. Results: Statistically significant improvement
was noted in the third attempt to SRT in reaction time for correct answers, p = 0.045, r = 0.24.
Moreover, significant improvement was noted in VAT reaction time, number of correct answers and
errors committed, p = 0.02, omega = 0.03, p = 0.007, r = 0.34 and p = 0.004, r = 0.35, respectively.
Non-significant changes were noted in other cognitive tests. Conclusions: A substantial number of
participants were unwilling or unable to complete the exercise programme. ME/CFS patients able to
complete the SEP showed improved visual attention both in terms of reaction time and correctness of
responses and processing speed of simple visual stimuli.
Keywords: mental function; brain fog; cognitive impairment
1. Introduction
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder characterised
by symptoms including chronic fatigue, exercise intolerance, disordered cognitive functions, autonomic
dysfunction, pain, and non–restorative sleep. To date, the specific aetiology of ME/CFS has not been
determined [1,2].
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The Institute of Medicine (IOM) report in 2015 highlighted an increasing body of literature
indicating neurocognitive impairment to be a key symptom in many people with ME/CFS [3].
Cognitive dysfunction includes problems with short-term memory, concentration, attention, processing
function, with an impact on everyday activities including work, leisure activities, reducing perceived
quality of life [3]. Between 50% to 85% of ME/CFS patients note subjective cognitive impairments [4].
So called “brain fog” is often described by those affected as one of the most debilitating symptoms of
the condition [5–8]. Other aspects of brain function appear unaffected, with higher-level cognitive
areas, such as verbal memory, visuo-spatial memory and linguistic fluency appearing normal [9].
However, objective methods of measuring cognitive functioning in those with ME/CFS indicate more
global, nonspecific deficits. These primarily include a general slowdown in response speed to tasks
that require simple and complex information processing as well as the ability to focus on a task [10].
Studies also confirm that cognitive disturbances of ME/CFS patients are restricted to a decrease in basic
processing speed and not related to depression severity [9,11]. Moreover, reduced attention capacity
manifesting in disturbed performance on effortful tasks based on planned and self-ordered responses
requires the use of short-term memory capacity [12]. Research appears to be suggesting that in ME/CFS
some cognitive function domains are more impaired than others with further research needed to
quantitatively measure cognitive impairment in ME/CFS and effectiveness of potential therapies
Measuring the efficiency of cognitive function is a research challenge. Although there are theoretical
distinctions in the field of cognitive science for brain regions associated with memory, attention and
psychomotor performance, in practice there are no tools to measure the individual cognitive functions
that usually occur together. Therefore, when the result of a specific neuropsychological test is interpreted
as a deficit (e.g., impaired short-memory performance), it is likely that other functions will also be
affected as tests usually measure many aspects of cognitive functioning simultaneously [3]. In ME/CFS
the mechanisms underlying both subjective and objective cognitive dysfunctions have not yet been
thoroughly investigated. Further research is needed to explain the likely biological basis of cognitive
deficits [13]. Currently, therapy for those with ME/CFS remains supportive with a focus upon activity
management [14]. A structured exercise programme (SEP) for chronic fatigue syndrome has been
shown to be effective in some patients, although this remains controversial [15]. Various randomized
controlled trials have demonstrated that a form of structured exercise programme for ME/CFS can lead
to a significant decrease in fatigue and disabilities [16–18]. However, crucially the long-term efficacy of
this has been disputed with such participants demonstrating a statistically non-significant difference in
fatigue and disability compared to patients allocated to receiving standard medical care (SMC) for at
least 2 years follow-up [19–21].
There is growing evidence of a link between cardiovascular and muscular deconditioning
and cognitive dysfunction in ME/CFS. In a cohort of females with ME/CFS, lower peak heart rate
and peak oxygen uptake (assessed during a cycle ergometer exercise task) were associated with a
slowed psychomotor response speed [22]. Another study identified a correlation between upper
limb muscle function recovery after a fatiguing physical task with information processing speed and
sustained attention [23]. These findings suggest that better physical health may lead to improved
cognitive outcomes in ME/CFS patients. In fact, improved physical fitness can have positive effects on
cognitive functioning [24]. Participants executed selective and persistent attention, cognitive inhibition,
and working memory capacity tests. After one week, participants executed fatigue-inducing upper
limb exercise. It was found that the return of upper limb muscle function is an important predictor
of cognitive performance in patients with CFS [24]. Moreover, significant heterogeneity of examined
patients was underlined [24].
Aerobic physical exercise programs have been proposed as an intervention that could improve
cognitive function in older people [25] and children [26]. Cvejic et al. [16] examined the effects of a
SEP on subjective and objective neurocognitive performance in ME/CFS for the first time. However,
more work in this field is needed, therefore the aim of this study was to test the influence of SEP upon
functioning of ME/CFS patients with a specific focus in cognitive function. Not all ME/CFS patients can
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complete a SEP programme and for some it is too difficult. Therefore, in this study we only examine
the impact of SEP on ME/CFS patients who managed to complete the 16 week programme.
2. Materials and Methods
2.1. Study Group
Study was conducted in Department of Hygiene, Epidemiology and Ergonomic, Collegium
Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun´, Poland. 1400 patients applied to
take part in the study and were assessed for eligibility. 1308 were excluded during initial screening
due to the presence of other conditions presumably explaining persistent fatigue. Neurological,
neurodegenerative, psychiatric and immunologic disorders which were excluding factors comprised
those of which mechanisms might presumably explain primary symptoms of ME/CFS. Ninety two
volunteers were enrolled into the trial (Figure 1)—all of them were initially diagnosed as CFS patients
based on Fukuda criteria [27]. The study was approved by the Ethics Committee, Ludwik Rydygier
Memorial Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun. The 92 patients
underwent a baseline assessment that included, body composition analysis, fatigue assessment and
autonomic nervous system functioning. Baseline results allowed us to exclude a further 23 patients
with other conditions which could explain the presence of persistent fatigue.
Brain Sci. 2020, 10, 4 3 of 12 
 
can complete a SEP programme and for some it is too difficult. Therefore, in this study we only 
examine the impact of SEP on ME/CFS patients who managed to complete the 16 week programme. 
2. Materials and Methods 
2.1. Study Group 
Study was conducted in Department of Hygiene, Epid miology and Erg omic, Collegium 
Medicum in Bydgoszcz, Nicolaus C per icus University in Toruń, Poland. 1400 patients applied to 
take part in the study and were assessed for eligibility. 1308 were excluded during initial screening 
due to the presence of other conditions presumably explaining persistent fatigue. Neurological, 
neurodegenerative, psychiatric and immunologic disorders which were excluding factors comprised 
those of which mechanisms might presumably explain primary symptoms of ME/CFS. Ninety two 
volunteers were enrolled into the trial (Figure 1)—all of them were initially diagnosed as CFS patients 
based on Fukuda criteri  [27]. The study was approved by the Ethics Committ e, Ludw k Rydygier 
Memorial Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toru . The 92 
pati nts u d rwent a basel ne asses ment that included, body composition analysis, fatigue 
assessment and autonomic nervo s system functioning. Bas lin  results allowed us to exclude a 
further 23 patients with other conditions which could explain the pre ence of persiste t fatigue. 
Sixty nine patients were invited to attend a second day of assessm nt which consi ted of 
cardiop lmonary exercise testing (CPET) and explana ion of the SEP pro ocol. Ho ever, 16 d scribed 
themselves as unable to u dergo CPET be ause of th  anticipated post-exe tional malaise symptoms 
during and after exertion. In total, 53 patients underwent a SEP protocol of 16 weeks. Thirty four 
64.2% patients completed the intervent on and under ent a follow up assessment that included 
fatigue, CPET and autonomic nervous syst m assessments (Figure 1). 
 
Figure 1. CONSORT-type flow diagram. 
Figure 1. CONSORT-type flow diagram.
Sixty nine patients were invited to attend a second day of assessment which consisted of
cardiopulmonary exercise testing (CPET) and explanation of the SEP protocol. However, 16 described
themselves as unable to undergo CPET because of the anticipated post-exertional malaise symptoms
during and after exertion. In total, 53 patients underwent a SEP protocol of 16 weeks. Thirty four 64.2%
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patients completed the intervention and underwent a follow up assessment that included fatigue,
CPET and autonomic nervous system assessments (Figure 1).
2.2. Initial Examination of Patients
2.2.1. Cognitive Function Measurement
To measure cognitive function the computerized battery test—Test Sprawnos´ci Operacyjnej
(TSO) (software version 4.6.0.44744, Speednet sp. z. o. o., more information available on: http:
//www.biostat.com.pl/news/nowa_aplikacja_tso_stat_-181.php) was used [28]. The following tests
were included: Simple Reaction Time (SRT), Choice Reaction Time (CRT), Visual Attention Test (visual
version of match to sample—VAT) and Delayed Matching to Sample (DMS). SRT measures visual
information processing speed, CRT is decision making test, VAT measures visual sustained attention,
DMS is a test of visual form of short-term memory test. Before starting battery test, short practice of
each test was introduced for every patient. Too fast, too slow, or inadequate (wrong or double-pressed
key) responses were treated as an error in this battery. At the beginning of every test text instruction
was displayed until participant confirm that he/she read it fully by pressing a “space” key on the
keyboard. The type of the stimuli was randomly picked from one of five sets: geometrical shapes,
plants and animal shapes, arrows, letters or numbers. Proper and distractor stimuli were randomly
selected by the software before each trial, all were presented on white background on 15,6”, screen.
Whole battery test consisted of subtests in the following order: SRT, CRT, SRT, VAT, DMS and SRT.
The SRT test was repeated three times during the test period. On average test duration was 12 min
duration (i.e., between the start of whole battery test, and start of the last SRT test). Overall there was a
2 min 20 s interval between start time of first and second SRT test. The following SRT attempts are
denoted as SRT.1, SRT.2 and SRT.3.
2.2.2. Structured Exercise Programme
Our SEP protocol is based on the deconditioning and exercise intolerance theories of chronic
fatigue syndrome, which could be described as vicious cycle [29]. ME/CFS has been hypothesized to be
linked to deconditioning and avoidance of physical activity [29]. Gradual deconditioning eventually
leads to an increased effort sensation which leads to an even lower level of physical activity. The aim of
SEP is to break this vicious cycle and gradually return the subject to the appropriate level of physical
activity level reversing the deconditioning and eventually reducing fatigue and disability [30]. Our SEP
is similar to the NICE recommended [14] graded exercise therapy, although initial %HRmax ranged
30–40%, depending on the CPET result. Patients had a period for the first 3–4 weeks adaptation at
very low HRmax levels. These modifications have been developed after feedback from patients in our
clinic with the aim of improving participation. However, a growing consensus mandating the presence
of post exertional malaise (PEM) [3]; a phenomenon which is not apparent in deconditioned healthy
controls, in the diagnosis of ME/CFS puts the causative notion of cardiopulmonary deconditioning
as principal driver of symptomatology into question. In comparison, Fulcher and White provided
programme with initial bouts lasting 15 min at an intensity of 40% of peak oxygen consumption
at least 5 days a week [31], while Moss-Morris et al. [24] provided programme with initial bouts
duration of 10–15 min 4 to 5 times a week with the intensity of 40 per cent of VO2max. Eventually
%HRmax reached 70–80% for 40 min with additional 7 stretching exercises in a training bout in the
SEP programme provided in the above study. Fulcher et al. eventually increase the duration to 30 min
with a maximum of 60% of peak oxygen consumption while in the case of Moss-Morris target HRmax
was 80% for 30 min 5 days a week.
Based on individual CPET results, physiotherapists introduced the patient to a personalised
exercise protocol including a demonstration of stretching exercises to be carried out as part of the plan.
Home exercise was prescribed at least five days a week, 16 weeks in total, with the initial 3 sessions
lasting approximately 10 min. Initially patients were asked to perform training bouts with the intensity
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of 30–40% of HRmax prescribed individually to patients depending on the CPET result. During the
training plan exercise intensity was gradually increased. After the first 3 training sessions, aerobic
exercise duration was increased to 20 min with 10% higher intensity in terms of %HRmax; moreover,
3 stretching exercises were added to each training session. Intensity, duration and number of stretching
exercises were gradually increased with subjects exercising to between 70–80% of HR max for 40 min
with an additional 7 stretching exercises as it was used in previous research [31]. Patients did not
exceed their HR max. Telephone calls were made weekly to ensure patients were satisfied with the
protocol and identify any problems with compliance. Patients were equipped with heart rate monitors
(Beurer PM 25) to help them in sustaining the recommended heart rate. The main exercise was walking
however subjects had an opportunity to use other modes of exercise, such as cycling and swimming
on request.
2.2.3. Statistical Methods
Shapiro-Wilk test was used to test the assumption of normality. Variables where values did not
meet the assumption of distribution normality were analysed using Wilcoxon signed-rank test to
compare before vs after intervention. Both T, Z and p values derived from the output of this test are
provided. For normally distributed variables repeated-measures ANOVA was used. Effect size for
Wilcoxon signed-rank test was calculated based on the following formula [32]:
r =
Z√
N
where Z is the z-score from applied nonparametric test and n is the size of the study.
For repeated-measures ANOVA test, following effect size formula was used [32]:
ω2 =
[
k−1
nk (MSM −MSR)
]
MSR +
MSB− MSR
k +
[
k−1
nk (MSM −MSR)
]
Violin graphs were created using an R statistical package [33] with a ggstatsplot library [34].
A Benjamini-Hochberg Adjusted p value was chosen to control for False Discovery Rate (FDR) using
an online calculator available at (https://tools.carbocation.com/FDR). p values both before and after
FDR correction are reported.
3. Results
Influence of SEP on Cognitive Function
A statistically significant improvement was noted in reaction time for correct answers in the third
SRT attempt (SRT3) (556.24 ms in SRT3 before SEP vs 504.15 in SRT3 after), T = 179.5, z = 2.02, p = 0.045,
r = 0.24 (Figure 2).
A statistically significant improvement was observed in the number of correct answers and errors
committed in VAT (53.77 before vs. 55.47 after SEP), T = 118.5, z = 2.72, p = 0.007, r = 0.34 and 6.68
before vs. 4.68 after SEP), T = 120.5, z = 2.86, p = 0.004, r = 0.35, respectively (Figures 3 and 4).
In addition, the reaction time for correct answers in VAT was significantly reduced after SEP
(1561.94 ms before vs 1473.03 after, F = 5.78, p = 0.02, omega = 0.03) (Figure 5).
No significant changes were observed for other cognitive tests (Table 1). Moreover, none of the
statistically significant results survived after FDR correction (Table 1).
Brain Sci. 2020, 10, 4 6 of 11
Brain Sci. 2020, 10, 4 6 of 12 
 
 
Figure 2. Influence of SEP on reaction time on correct responses in SRT.3. 01_before denotes time 
point before SEP, while 02_after indicates time point after SEP. Red dots connected by red line 
indicates mean value, horizontal black line inside the box denotes median value. Green dots before 
and orange dots after connected by dashed lines denotes results of individual patients. Shape of violin 
graph indicates distribution of results. 
A statistically significant improvement was observed in the number of correct answers and 
errors committed in VAT (53.77 before vs. 55.47 after SEP), T = 118.5, z = 2.72, p = 0.007, r = 0.34 and 
6.68 before vs. 4.68 after SEP), T = 120.5, z = 2.86, p = 0.004, r = 0.35, respectively ( Figure 3;  Figure 4). 
Figure 2. Influence of SEP on reaction time on correct responses in SRT.3. 01_before denotes time point
before SEP, while 02_after indicates time point after SEP. Red dots connected by re line indicates mean
value, horizontal black lin inside the box d notes median value. Green dots b fore and orange dots
after connected by dashed lines denotes results of individual patients. Shape of violin graph indicates
distribution of results.Brain Sci. 2020, 10, 4 7 of 12 
 
 
Figure 3. Effects of SEP on number of correct responses in VAT. 01_before denotes time point before 
SEP, while 02_after indicates time point after SEP. Red dots connected by red line indicates mean 
value, horizontal black line inside the box denotes median value. Green dots before and orange dots 
after connected by dashed lines denotes results of individual patients. Shape of violin graph indicates 
distribution of results. 
 
Figure 4. Effects of SEP on errors committed in VAT. 01_before denotes time point before SEP, while 
02_after indicates time point after SEP. Red dots connected by red line indicates mean value, 
horizontal black line inside the box denotes median value. Green dots before and orange dots after 
connected by dashed lines denotes results of individual patients. Shape of violin graph indicates 
distribution of results. 
Figure 3. Effects of SEP on number of correct responses in VAT. 01_before denotes time point before
SEP, while 02_after indicates time point after SEP. Red dots connected by red line indicates mean value,
horizontal black line inside the box denotes median value. Green dots before and orange dots after
connected by dashed lines de otes results of individual patients. Shape of v olin graph indicates
distribu ion of results.
Brain Sci. 2020, 10, 4 7 of 11
Brain Sci. 2020, 10, 4 7 of 12 
 
 
Figure 3. Effects of SEP on number of correct responses in VAT. 01_before denotes time point before 
SEP, while 02_after indicates time point after SEP. Red dots connected by red line indicates mean 
value, horizontal black line inside the box denotes median value. Green dots before and orange dots 
after connected by dashed lines denotes results of individual patients. Shape of violin graph indicates 
distribution of results. 
 
Figure 4. Effects of SEP on errors committed in VAT. 01_before denotes time point before SEP, while 
02_after indicates time point after SEP. Red dots connected by red line indicates mean value, 
horizontal black line inside the box denotes median value. Green dots before and orange dots after 
connected by dashed lines denotes results of individual patients. Shape of violin graph indicates 
distribution of results. 
Figure 4. Effects of SEP on errors co mitted in VAT. 01_before denotes time point before SEP,
while 02_after indicates time point after SEP. Red dots connected by red li e indicat s mean value,
horizontal black line inside the box denotes value. Green dots before and orange dots after
connected by dashed lines denotes results of i i i al patients. Shape of violin graph indicates
distribution of results.
Brain Sci. 2020, 10, 4 8 of 12 
 
In a dition, t  r act on time for correct a swers in VAT was significantly reduced aft r SEP 
(1561.94 ms before v  1473.03 after, F = 5.78, p = 0.02, omega = 0.03) (Figure 5). 
 
Figure 5. Effects of SEP on reaction time in correct response in VAT. 01_before denotes time point 
before SEP, while 02_after indicates time point after SEP. Red dots connected by red line indicates 
mean value, horizontal black line inside the box denotes median value. Green dots before and orange 
dots after connected by dashed lines denotes results of individual patients. Shape of violin graph 
indicates distribution of results. 
No significant changes were observed for other cognitive tests (Table 1). Moreover, none of the 
statistically significant results survived after FDR correction (Table 1). 
  
Figure 5. Effects of SEP on reaction ti e in correct response in VAT. 01_before denotes time point
before SEP, while 02_after indicates time point after SEP. Red ots connected by red line indicates mean
value, horizontal black line inside the box denotes m dian value. Green dots before an e dots
after c nnected by dashed lines denotes result of individual patients. Shape of vi lin graph indicates
distribution of results.
Brain Sci. 2020, 10, 4 8 of 11
Table 1. Effects of SEP on cognitive function test results.
Variable Mean (SD) Before Mean (SD) After p FDR
SRT.1 correct answers 19.47 (0.99) 19.47 (0.83) 0.89 1.07
SRT.1 errors 0.53 (0.99) 0.53 (0.83) 0.89 1
SRT.1 correct reaction time 547.09 (162.59) 520.56 (129.67) 0.22 0.79
SRT.2 correct answers 19.18 (2.59) 19.71 (0.68) 0.34 1.02
SRT.2 errors 0.82 (2.59) 0.32 (0.68) 0.44 0.88
SRT.2 correct reaction time 540.24 (188.58) 517.32 (106.68) 0.62 0.80
SRT.3 correct answers 19.62 (0.60) 19.59 (0.66) 1.00 1.06
SRT.3 errors 0.38 (0.60) 1.59 (7.33) 1.00 1
SRT.3 correct reaction time 556.24 (157.99) 504.15 (97.28) 0.04 0.18
CRT correct answers 29.24 (0.89) 29.44 (0.75) 0.41 1.05
CRT errors 0.77 (0.89) 0.62 (0.82) 0.53 0.80
CRT correct reaction time 617.97 (175.24) 596.21 (119.01) 0.56 0.78
VAT correct answers 53.77 (3.49) 55.47 (2.85) 0.007 0.06
VAT errors 6.68 (3.88) 4.68 (2.96) 0.004 0.07
VAT correct reaction time 1561.94 (216.66) 1473.03 (232.90) 0.02 0.12
DMS correct answers 22.35 (3.54) 22.94 (3.48) 0.48 0.79
DMS errors 10.82 (3.73) 10.71 (5.58) 0.43 0.97
DMS correct reaction time 1473.59 (265.46) 1418.79 (360.73) 0.47 0.85
4. Discussion
The main conclusion of our study is that ME/CFS patients who completed a structured exercise
programme improved in terms of (i) correctness of responses in visual attention test, (ii) reaction time
in visual attention test, (iii) processing speed of simple visual stimuli. However, a number of patients
did not improve and none of the effects remained significant after FDR correction.
Robinson et al. [11] in an examination of cognitive function in ME/CFS patients identified that
cognitive disturbances are limited to decrease in basic processing speed. Based on our findings it
can be concluded that these aspects of cognitive functioning could be improved in some ME/CFS
patients by SEP. Similar results have been obtained in older subjects following physical exercise
programmes [25]. In the case of the effects of a physical exercise programme on cognitive function in
children, adolescents and young adults Verburgh et al. [25] concluded that more studies are needed,
however, they suggested that acute physical exercise improved executive functioning. In a study by
Blackwood et al. [35] physical exercise training significantly reduced the decline of ME/CFS patients in
a Telephone search task over time, while no significant changes were observed in a Digit Span, Digit
Span Backward, Digit Symbol Substitution Test and Word fluency when compared to major depressive
disorder patients and healthy controls. In depressive disorders physical exercise programs are an
effective non-pharmacological adjunctive therapy [19,36]. Importantly, in this study a diagnosis of
psychiatric disease resulted in exclusion of patients from the study. It is important to acknowledge the
significant dropout rate (35 from 69 patients (50.7%)) who following CPET assessment or proceeding
initiation of the SEP programme did not complete the programme. This is consistent with other studies
where a 50% drop out rate was observed within 6–12 months of starting to exercise regularly [37–39].
Overall, it could be concluded that both acute physical exercise bout and effects of physical exercise
programme can lead to cognitive function improvement in many patient populations. However,
in the case of ME/CFS patient’s further research on this topic is needed because participation in a
physical exercise programme has the potential to induce post-exertional malaise at least in some
participants [40]. The high drop-out rate amongst ME/CFS patients in this study with a number of
individuals not showing improved cognitive function highlights the need for care in advocating SEP
therapy and the potential heterogeneity of this patient group. It is therefore important, that those who
are engaging in a structured exercise programme where there might be potential benefits are fully
informed of possible detrimental effects with regular contact with the clinical team. Also research
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focussing upon risk stratification that allows specific phenotypes who are more likely to benefit from
exercise based interventions (and those who are not) is much needed.
Being able to identify sub-groups of patients who benefit or are harmed by any treatment
programme before participation is of great importance as we look to find interventions which can
improve the lives of ME/CFS patients. At the moment the utmost care must be taken by clinicians
in guiding ME/CFS patients exhibiting a worsening of symptomatology following exertion (PEM) to
commence a graded exercise programme. In the current study we noted a significant improvement
in objective neurocognitive performance in patients with ME/CFS after SEP programme. This is
an encouraging observation as it is widely acknowledged that subjective complaints and objective
performance indices do not correlate well [17]. Many improvements presented in previous studies
are based exclusively on self-report measures [17,41]. Cvejic et al. [16] provide the first evidence
of improvements in subjective and objective neurocognitive performance after the completion of a
12-week structured exercise programme incorporating a cognitive training component with objective
outcome measures. Also, Cvejic et al. noted an objective neurocognitive performance improvements
were accompanied by a significant reduction in responsiveness in stress-related neural pathways
consequent to an exercise programme. Further studies could aim to examine the effects of combination
of two therapeutic strategies (SEP and self-help neurocognitive training) to maximize improvement
after intervention for a select group of ME/CFS patients that do not respond adversely (absence of or
lesser severity of PEM) to physical (SEP) and neurocognitive exertion. Moreover, the maintenance of
cognitive function improvement with SEP over greater longitude has yet to be determined.
These findings and our results support the idea of the effectiveness of such activity therapies in
remediating clinical cognitive status in ME/CFS patients. Our findings warrant further investigation,
including replication in a larger sample with proper control group applied but with caveat in that we
need to identify potential responders and non-responders before embarking on such programmes.
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